Alpha Teknova (TKNO) Net Income Growth (1y) (2021 - 2026)
Alpha Teknova (TKNO) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -384.49% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -14.93% |
| 10 | Alpha Teknova | 264.01 Mn | 246.23 Mn | 3.78 Mn | 1.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94% |
| Dec 31, 2025 | 17.35% |
| Sep 30, 2025 | 43.07% |
| Jun 30, 2025 | 33.45% |
| Mar 31, 2025 | 42.63% |
| Dec 31, 2024 | 47.82% |
| Sep 30, 2024 | 25.49% |
| Jun 30, 2024 | 25.02% |
| Mar 31, 2024 | 8.17% |
| Dec 31, 2023 | 27.88% |
| Sep 30, 2023 | 54.77% |
| Jun 30, 2023 | -15.42% |
| Mar 31, 2023 | -61.60% |
| Dec 31, 2022 | -134.36% |
| Sep 30, 2022 | -592.20% |
| Jun 30, 2022 | -177.56% |
| Mar 31, 2022 | -732.98% |
| Dec 31, 2021 | -343.12% |
| Sep 30, 2021 | -311.55% |
| Jun 30, 2021 | -526.96% |